Maité Callewaert

Dr. Maité Callewaert

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 July 2014 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
MCMaité Callewaert
Maité Callewaert
VRV Gaelle ROULLIN
V Gaelle ROULLIN
CCCyril Cadiou
Cyril Cadiou
EMElodie Millart
Elodie Millart
LGLaurence VAN GULICK
Laurence VAN GULICK
FCFrançoise CHUBURU
Françoise CHUBURU
A series of hydrogel nanoparticles incorporating MRI contrast agents (GdDOTP and MS325) as potential cross-linkers were elaborated by an easy and robust ionotropic gelation process. By this process, high Gd loadings were obtained (between 1.8 and 14.5 × 104 Gd centres per NP). By tuning the cross-linker ionization degree and the nature of the polymer matrix it was possible to boost the r1 relaxivity per Gd centre up to 22-fold. The greatest gains in relaxivity were observed for nanogels for which the polymer matrix was constituted of chitosan and hyaluronan. Relaxivities per Gd centre as high as 100 s−1 mM−1 at 30 MHz can be reached, which highlighted the fact that molecular motion of the Gd chelate was effectively restricted and water access to the inner core of these nanogels was not limited.

28 December 2016 in Nanotechnology
Verified
Journal Article
Closed access
PDF file
GRG Rigaux
G Rigaux
CGC V Gheran
C V Gheran
MCMaité Callewaert
Maité Callewaert
CCC Cadiou
C Cadiou
SVSorina Nicoleta Voicu
Sorina Nicoleta Voicu
FCFrançoise CHUBURU
Françoise CHUBURU
Chitosan CS—tripolyphosphate TPP/hyaluronic acid HA nanohydrogels loaded with gadolinium chelates (GdDOTA ⊂ CS-TPP/HA NGs) synthesized by ionic gelation were designed for lymph node (LN) MRI. In order to be efficiently drained to LNs, nanogels (NGs) needed to exhibit a diameter ϕ < 100 nm. For that, formulation parameters were tuned, using (i) CS of two different molecular weights (51 and 37 kDa) and (ii) variable CS/TPP ratio (2 < CS/TPP < 8). Characterization of NG size distribution by dynamic light scattering (DLS) and asymetrical flow-field-flow-fractionation (AF4) showed discrepancies since DLS diameters were consistently above 200 nm while AF4 showed individual nano-objects with ϕ < 100 nm. Such a difference could be correlated to the presence of aggregates inherent to ionic gelation. This point was clarified by atomic force microscopy (AFM) in liquid mode which highlighted the main presence of individual nano-objects in nanosuspensions. Thus, combination of DLS, AF4 and AFM provided a more precise characterization of GdDOTA ⊂ CS-TPP/HA nanohydrogels which, in turn, allowed to select formulations leading to NGs of suitable mean sizes showing good MRI efficiency and negligible toxicity.

28 March 2018 in Nanomaterials
Verified
Journal Article
Open access
PDF file
CGCecilia Virginia Gheran
Cecilia Virginia Gheran
GRGuillaume Rigaux
Guillaume Rigaux
MCMaité Callewaert
Maité Callewaert
ABAlexandre Berquand
Alexandre Berquand
michael molinarimichael molinari
michael molinari
Anca DinischiotuAnca Dinischiotu
Anca Dinischiotu
Although the research on nanogels incorporating Gd chelates for theranostic applications has grown exponentially in recent years, knowledge about their biocompatibility is limited. We compared the biocompatibility of Gd-loaded hyaluronic acid-chitosan-based nanogels (GdCA⊂CS-TPP/HA) with two chitosan concentrations (2.5 and 1.5 mg·mL−1 respectively) using SVEC4-10 murine lymph node endothelial cells. The sulforhodamine B method and released lactate dehydrogenase (LDH) activity were used as cell viability tests. Reactive oxygen species (ROS), reduced glutathione (GSH) and malondialdehyde (MDA) were measured by spectrophotometric and fluorimetric methods. Nrf-2 protein expression was evaluated by Western blot analysis and genotoxicity by alkaline comet assay. After 24 h, the cells viability was not affected by all types and doses of nanogels. The increase of ROS induced a low decrease of GSH concentration and a time-dependent raise of MDA one was produced by citric GdDOTA⊂CS-TPP/HA with a chitosan concentration of 1.5 mg·mL−1, at the highest dose applied. None of the tested nanogels induced changes in Nrf-2 protein expression. A slight but significant genotoxic effect was caused only by citric GdDOTA⊂CS-TPP/HA where CS concentration was 1.5 mg·mL−1. Our results showed a better biocompatibility with lymph node endothelial cells for Gd-loaded hyaluronic acid-chitosan based nanogels with a concentration in chitosan of 2.5 mg·mL−1.

7 October 2021 in Cancers
Verified
Journal Article
Open access
PDF file
AJAlbin JEANNE
Albin JEANNE
TSThomas Sarazin
Thomas Sarazin
MCMagalie Charlé
Magalie Charlé
CMCatherine Moali
Catherine Moali
CFCaroline Fichel
Caroline Fichel
Stephane DedieuStephane Dedieu
Stephane Dedieu
TAX2 peptide is a cyclic peptide that acts as an orthosteric antagonist for thrombospondin-1 (TSP-1) interaction with CD47. TAX2 was first described for its anti-angiogenic activities and showed anti-cancer efficacy in numerous preclinical models. Here, we aimed at providing an extensive molecular characterization of TAX2 mode of action, while evaluating its potential in ovarian cancer therapy. Multidisciplinary approaches were used to qualify a TAX2 drug candidate in terms of stability, solubility and potency. Then, efficacy studies, together with benchmark experiments, were performed in relevant mouse models of ovarian carcinoma. TAX2 peptide appears to be stable and soluble in clinically relevant solvents, while displaying a favorable safety profile. Moreover, clinical data mining allowed for the identification of TSP-1 as a relevant pharmacological target in ovarian cancer. In mice, TAX2 therapy inhibits ovarian tumor growth and metastatic dissemination, while activating anti-cancer adaptive immunity. Interestingly, TAX2 also synergizes when administered in combination with anti-PD-1 immune checkpoint inhibitiors. Altogether, our data expose TAX2 as an optimized candidate with advanced preclinical characterization. Using relevant syngeneic ovarian carcinoma models, we highlighted TAX2’s ability to convert poorly immunogenic tumors into ones displaying effective anti-tumor T-cell immunity.

1 January 2005 in Journal of Adhesion Science and Technology
Verified
Journal Article
Closed access
MCMaité Callewaert
Maité Callewaert
PRPaul G. Rouxhet
Paul G. Rouxhet
LBLaurence Boulangé-Petermann
Laurence Boulangé-Petermann
The treatment of stainless steel surfaces with responsive polymers was investigated using X-ray photoelectron spectroscopy and scanning electron microscopy. Poly(N-isopropylacrylamide) (PNIPAAM) is...

1 July 2021 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
HRHASSAN RAMMAL
HASSAN RAMMAL
AAAlmar Al Assaad
Almar Al Assaad
Franco DosioFranco Dosio
Franco Dosio
Barbara StellaBarbara Stella
Barbara Stella
AMAndrei Maksimenko
Andrei Maksimenko
ABAbdelilah Beljebbar
Abdelilah Beljebbar